State Street’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

State Street’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-95,592	Closed	-$2.59M	–	3764
2015 Q4	$2.59M	Sell	95,592 -2,227	-2%	-$57.4K	﹤0.01%	2891
2015 Q3	$2.14M	Sell	97,819 -69,565	-42%	-$1.78M	﹤0.01%	2975
2015 Q2	$4.77M	Buy	167,384 +2,452	+1%	+$71.5K	﹤0.01%	2643
2015 Q1	$4.51M	Buy	164,932 +4,820	+3%	+$133K	﹤0.01%	2620
2014 Q4	$4.23M	Buy	160,112 +5,228	+3%	+$153K	﹤0.01%	2657
2014 Q3	$4.67M	Buy	154,884 +19,736	+15%	+$611K	﹤0.01%	2579
2014 Q2	$4.26M	Buy	135,148 +2,907	+2%	+$92.3K	﹤0.01%	2680
2014 Q1	$4.28M	Buy	132,241 +12,195	+10%	+$427K	﹤0.01%	2656
2013 Q4	$4.36M	Sell	120,046 -5,277	-4%	-$205K	﹤0.01%	2652
2013 Q3	$4.87M	Sell	125,323 -11,969	-9%	-$482K	﹤0.01%	2549
2013 Q2	$5.14M	Buy	+137,292	New	+$5.42M	﹤0.01%	2453

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State Street's MR Position: Q1 2016 in Review

State Street sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 95,592 shares — an estimated $2.59M sold.

State Street first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $5.14M in Q2 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

State Street reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
State Street sold 95,592 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $2.59M.
State Street first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
State Street's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $5.14M in Q2 2013.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on State Street's 13F filing for Q1 2016, filed 12 May 2016.